• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi , April 26

PANACEA Biotec has launched UpRight (a fixed dose combination of aceclofenac and paracetamol), which claims to offer relief from severe pain and inflammation. While aceclofenac relieves pain and inflammation through a variety of mechanisms, paracetamol is an effective analgesic-antipyretic agent.

In a statement, Mr Rajesh Jain, Joint Managing Director, Panacea Biotec, said, "Our quest for providing a holistic solution for severe painful and inflammatory conditions has lead to the launch of UpRight. This is superior to other NSAIDs (non-steroidal anti-inflammatory drugs)."

The drug can be prescribed for severe pain and inflammation indications in osteoarthritis, rheumatoid arthritis, spondylitis, low back pain, dental pain, pelvic pain and also for painful and inflammatory conditions of ear, nose and throat.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
NCL, DuPont sign research pact

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line